Nearly 300 employees in Lawrenceville will lose their jobs as part of a pharmaceutical company's major cost-cutting measures, ...

As Bristol Myers Squibb rolls ahead with its plan to cut $1.5 billion in costs by the end of the year, the drugmaker is once ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s ...

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets ...

Sandra Leung, one of the longest-serving legal chiefs in the pharmaceutical industry, plans to retire from Bristol Myers Squibb in ... The Princeton, New Jersey-based company whose blockbuster ...

I will point out why Bristol-Myers Squibb's share price still does not reflect the success in commercializing its drugs. Even though the Princeton, New Jersey-based company was able to beat the ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s stock price hit a new 52-week high during trading on Friday .The stock traded as high as $61.68 and last traded at $61.90, with a volume of ...

we estimate Bristol Myers Squibb’s valuation to be around $61 per share, aligning closely with the current market price. While new drug approvals offer potential upside, the immediate financial ...

European Commission approves Bristol Myers Squibb’s Opdivo plus Yervoy for first-line treatment of adult patients with unresectable or advanced HCC: Princeton, New Jersey Monday ...

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets biopharmaceutical products. Valued at a market cap of $121.4 billion ...